In a data-driven world, pauses in government economic reporting do more than inconvenient economists, they create dangerous blind spots for investors, policymakers, and business leaders. When ...
The cost of GLP-1 medications to group health plans continues to increase rapidly as FDA approval expands and the percentage of participants and beneficiaries taking GLP-1 medications rises. This ...
Even the thought of the proposed Department of Labor fiduciary regulations regarding commissions are adding a layer of consternation and disruption to the industry’s conventional model. Lloyd Lofton ...
AI’s edge may come not from more consumer data, but from better signals on consumer emotions, expectations and intentions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results